Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06833476 · ClinicalTrials.gov registry record
TTVR STRONG Under Coverage With Evidence Development (CED) Study
A clinical trial of Tricuspid Regurgitation, sponsored by Edwards Lifesciences.
- Recruiting
- Registry status
- 2,044
- Enrollment target
- 1
- Study location
NCT06833476 is a study of Tricuspid Regurgitation that is actively recruiting participants, run by Edwards Lifesciences. The registered enrollment target is 2,044 participants, above the 415-participant average among 17 other Tricuspid Regurgitation trials with a reported enrollment target (393% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06833476, a study of Tricuspid Regurgitation, is actively recruiting participants, sponsored by Edwards Lifesciences.
- RECRUITING
- Registry status
- 2,044 participants
- Enrollment target
- 1
- Study location
Study Summary
This Coverage with Evidence Development (CED) study measures the long-term health outcomes of patients with severe, symptomatic Tricuspid Regurgitation who received a Transcatheter Tricuspid Valve Replacement procedure using the EVOQUE system.
Conditions Studied
Interventions
- OTHER EVOQUE
Study Locations (1)
California
- Edwards Lifesciences - Irvine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,044 participants |
| Start Date | 2025-03-19 |
| Est. Completion | 2032-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06833476
The ClinicalTrials.gov registry entry for NCT06833476 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,044 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 415-participant average among 17 other Tricuspid Regurgitation trials with a reported enrollment target (393% higher). The listed sponsor is Edwards Lifesciences, which has 57 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tricuspid Regurgitation appearing as the primary indexed condition, and to 1 intervention - of which EVOQUE is the first listed.
NCT06833476 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06833476 about?
NCT06833476 is a clinical study titled "TTVR STRONG Under Coverage With Evidence Development (CED) Study". This Coverage with Evidence Development (CED) study measures the long-term health outcomes of patients with severe, symptomatic Tricuspid Regurgitation who received a Transcatheter Tricuspid Valve Replacement procedure using the EVOQUE system.
What is the current status of trial NCT06833476?
This trial is currently recruiting. The enrollment target is 2,044 participants. The study started on 2025-03-19. Estimated completion is 2032-12-31.
What conditions does trial NCT06833476 study?
This clinical trial studies the following conditions: Tricuspid Regurgitation.
What interventions are being tested in trial NCT06833476?
The interventions under investigation include: EVOQUE (OTHER).
Who is sponsoring clinical trial NCT06833476?
This trial is sponsored by Edwards Lifesciences, which has 57 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06833476 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tricuspid Regurgitation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study
RECRUITING
-
TTVR Early Feasibility Study
RECRUITING · NA
-
Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation ( VISTA-US)
RECRUITING · NA
-
Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System
RECRUITING · NA
-
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
RECRUITING · NA
-
Trisol System EFS Study
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.